Almac Sciences, an established, leading contract development and manufacturing organisation provides services for all stages of drug development for small molecules and peptides. Our expertise includes: API supply (preclinical to commercial manufacture); drug product development; stable and 14C radiolabelling; solid state services; biocatalysis, all of which are fully supported by a dedicated analytical team. Our biocatalysis team has expertise in enzyme engineering, enzyme supply, enzyme screening, developing new routes and manufacturing at scale, both GMP and non-GMP.
Protéus by Seqens
Protéus is a pioneer in protein engineering technologies, with now 20 years expertise in developing tailored enzymes and scaling-up biocatalytic processes. Protéus is an affiliate of Seqens, an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering custom-made products and solutions to its customers. Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia. More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technology breakthroughs, we improve the performance, function and safety of our customers’ products. Our science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Johnson Matthey collaborates with our customers to make a real difference to the world around us.